LOXO-435,Pembrolizumab
Merck,eli lilly
['urothelial', 'urothelial carcinoma', 'solid tumor']
learn more at #aacr23 about our phase 1 study investigating an fgfr3 inhibitor in patients w/ fgfr3-altered advanced #urothelial carcinoma &amp; other solid tumors. trial in progress poster: #cancerresearch #clinicaltrials 
Dedicated to communicating the latest science & innovation from Loxo@Lilly. Tweets intended for US oncology HCPs. See our community guidelines: https://t.co/1q8vAe63mK